Literature DB >> 9059433

Hepatitis B and C in New South Wales prisons: prevalence and risk factors.

T G Butler1, K A Dolan, M J Ferson, L M McGuinness, P R Brown, P W Robertson.   

Abstract

OBJECTIVES: To determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among inmates entering the New South Wales correctional system and to examine risk factors for infection.
DESIGN: Cross-sectional survey.
SETTING: Reception Centre at Long Bay Correctional Centre, Sydney, New South Wales, June to December 1994. PARTICIPANTS: 408 adult male inmates received at the Reception Centre (28% of the 1450 new inmates eligible for compulsory HIV testing). OUTCOME MEASURES: Presence of HBV core and surface antibody and surface antigen; HCV antibody; risk factors; inmates' knowledge about risk factors.
RESULTS: 37% of inmates tested positive for HCV antibody, 31% for HBV core antibody and 3.2% for HBV surface antigen (indicating recent infection or carrier status). Among those who reported a history of injecting illegal drugs, rates rose to 66% for HCV antibody and 43% for HBV core antibody. Prevalence of HBV and HCV antibodies was similar in Aboriginal and non-Aboriginal inmates, but HBV antigen carrier rate was significantly higher among Aboriginals (12% versus 2.2%). Knowledge about hepatitis risk factors was poor (only 20% named injecting drug use), although recidivists were significantly better informed than those new to the correctional system. Multivariate analysis identified injecting drug use, past exposure to hepatitis B virus and previous imprisonments as significant predictors for HCV infection, and age over 25 years and HCV antibodies for HBV infection.
CONCLUSIONS: Results suggest that about a third of adult male prisoners entering the NSW correctional system may have been infected with HBV or HCV. Measures such as education about hepatitis risk factors and HBV vaccination are needed to reduce hepatitis transmission in this population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059433     DOI: 10.5694/j.1326-5377.1997.tb140041.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  28 in total

1.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.

Authors:  J Long; S Allwright; J Barry; S R Reynolds; L Thornton; F Bradley; J V Parry
Journal:  BMJ       Date:  2001-11-24

2.  In search of the correct strategy for preventing the spread of HCV infection.

Authors:  M Montella; A Crispo; J Wynn-Bellezza
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 3.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

4.  The effect of hepatitis C virus infection on health-related quality of life in prisoners.

Authors:  Hla-Hla Thein; Tony Butler; Murray Krahn; William Rawlinson; Michael H Levy; John M Kaldor; Gregory J Dore
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

5.  Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Seyed Moayed Alavian; Khalil Jafari; Nastaran Yazdi
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

6.  Contextualising professional ethics: the impact of the prison context on the practices and norms of health care practitioners.

Authors:  Karolyn L A White; Christopher F C Jordens; Ian Kerridge
Journal:  J Bioeth Inq       Date:  2014-07-11       Impact factor: 1.352

7.  Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users.

Authors:  J R Pallás; C Fariñas-Alvarez; D Prieto; M Delgado-Rodríguez
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

8.  Impact of a newly opened prison on an accident and emergency department.

Authors:  S H Boyce; J Stevenson; I S Jamieson; S Campbell
Journal:  Emerg Med J       Date:  2003-01       Impact factor: 2.740

9.  Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida.

Authors:  J S Weisbord; M J Trepka; G Zhang; I P Smith; T Brewer
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

10.  Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.

Authors:  Jennifer A Gates; Jeffrey J Post; John M Kaldor; Yong Pan; Paul S Haber; Andrew R Lloyd; Kate A Dolan
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.